Fulltext

The amphetamine sensitization model of schizophrenia: relevance beyond psychotic symptoms?

Peleg-Raibstein, Daria ; Yee, Benjamin ; Feldon, Joram ; Hauser, Jonas

In: Psychopharmacology, 2009, vol. 206, no. 4, p. 603-621

Ajouter à la liste personnelle
    Titre
    • The amphetamine sensitization model of schizophrenia: relevance beyond psychotic symptoms?
    Auteur
    • Peleg-Raibstein, Daria. Laboratory of Behavioural Neurobiology, Federal Institute of Technology Zurich, Schorenstrasse 16, 8603, Schwerzenbach, Switzerland
    • Yee, Benjamin. Laboratory of Behavioural Neurobiology, Federal Institute of Technology Zurich, Schorenstrasse 16, 8603, Schwerzenbach, Switzerland
    • Feldon, Joram. Laboratory of Behavioural Neurobiology, Federal Institute of Technology Zurich, Schorenstrasse 16, 8603, Schwerzenbach, Switzerland
    • Hauser, Jonas. Laboratory of Behavioural Neurobiology, Federal Institute of Technology Zurich, Schorenstrasse 16, 8603, Schwerzenbach, Switzerland
    Type de document
    • Postprint
    Identifiant OAI-PMH
    • oai:doc.rero.ch:319410
    Summary
    Rationale: A sensitized dopamine system may be linked to the genesis of psychotic symptoms in schizophrenia. Following withdrawal from amphetamine exposures, psychotic-like traits have been robustly demonstrated, but the presence of cognitive/mnemonic deficits remains uncertain. Methods: Adult male Lewis and Fischer rats, differing in cognitive performance, were exposed intermittently to escalating doses of amphetamine over 5weeks. This was effective in producing behavioral sensitization to a subsequent amphetamine challenge. Following 27days of drug withdrawal, the animals were assessed in Pavlovian conditioning, object recognition, and spatial working memory. In addition, prepulse inhibition (PPI), spontaneous motor activity, and anxiety-like behavior were measured. Results: Amphetamine pretreatment induced behavioral sensitization in both rat strains similarly. Working memory was enhanced in Fischer but not Lewis rats following withdrawal. Spontaneous novel object preference was enhanced in sensitized Fischer rats, but was impaired in sensitized Lewis rats, thus effectively reversing the strain difference in non-sensitized controls. In contrast, Pavlovian fear conditioning remained unaffected and so were anxiety-like behavior, open field activity, and PPI. Conclusion: The face validity of the amphetamine withdrawal model for cognitive deficits was limited to the object recognition memory impairment observed in sensitized Lewis rats. Yet, the possibility that enhancing dopaminergic neurotransmission may facilitate object recognition and spatial working memory performance was demonstrated in sensitized Fischer rats. Identification of the mechanisms underlying such strain-dependent effects would be instrumental in the further specifications of the construct validity, and therefore the limitations and potential of the amphetamine sensitization model of schizophrenia